Navigation Links
Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
Date:11/17/2010

development programme is designed to direct the patient's own stem cells into new heart cells with the potential to rebuild the heart.

The Cardio3 BioSciences team has extensive experience in developing and commercialising new pharmaceutical products and medical technologies and the Company's current strategy is to drive the clinical development of C-Cure and to market the product itself, if marketing authorisation is obtained, on a wide geographical scale.

Cardio3 BioSciences was founded in July 2007 and is based in Mont-Saint-Guibert (near Louvain-la-Neuve) in the Walloon region of Belgium.

About C-Cure and Heart Failure

Heart failure is a life-threatening and increasingly common condition in which the heart cannot pump enough blood through the body, leaving the patient debilitated and significantly decreasing quality of life. It can result from heart attacks or a number of other causes. Patients suffering from the condition can experience shortness of breath and extreme exhaustion. Based on available data, the company estimates that 84 million people suffer from heart failure and that this number will double by 2020. Therapies available for chronic heart failure aim at slowing disease progression, but with the exception of heart transplant, existing drugs or devices do not cure the underlying disease.

C-Cure is produced by taking a patient's own stem cells and, through a proprietary process, differentiating them into cardiac lineage ("cardiopoietic") cells designed to regenerate damaged heart muscle. Cardiopoietic cells are injected into the heart of the patient with heart failure where they aim to replace damaged tissue and promote repair without carrying the risk of rejection. This is the first product candidate of its kind offering the potential for heart muscle regeneration. C-Cure is being developed on the basis of multiple years of research conducted at Mayo Clinic (Rochester, Minnesota, USA) and clinical expertise g
'/>"/>

SOURCE Cardio3 BioSciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Award Winning Mayo Clinic Scientist Joins Cardio3 BioSciences
2. Cardio3 BioSciences Announces Promising Pre-Clinical Data for Proprietary C-Cath(R) Catheter
3. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
4. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
5. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
6. Magellan Biosciences to Debut Revolutionary New Dynex® Clinical Diagnostics Processing System for Fully Automated ELISA Testing at MEDICA 2010
7. Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference
8. Ambit Biosciences Strengthens Board of Directors and Executive Team
9. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
10. Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
11. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... VIEW, Calif. , Aug. 31, 2015 /PRNewswire/ ... for flow cytometry is experiencing a rise in ... the demand in underdeveloped nations to quantitate CD4 ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... Analysis of the Global Flow Cytometry Market ( ...
(Date:8/31/2015)... HARRISBURG, Pa. , Aug. 31, 2015 ... been reversed statewide since Pennsylvania ... the life-saving drug kits, naloxone. Heroin and ... in Pennsylvania , killing more individuals ... 2013, approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015  The departments of ... event today at Gaudenzia Concept 90 to raise awareness ... overdose crisis in Pennsylvania and ... and focus on recovery through the Building Bridges ... Pennsylvanians are dying every day to a disease that ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... Phase 1 Colorectal and Prostate Cancer,Trials To Be ... FRANCISCO, Calif., May 23, 2007 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, ... announced that data from a Phase 2 trial,of ... small cell lung cancer (SCLC) will be presented ...
... Urine Flow, With,Long Lasting Effect in Phase 2 ... Spectrum,Pharmaceuticals, Inc., today announced Phase 2 safety and ... the treatment,of benign prostatic hypertrophy (BPH), at the ... Convention Center in,Anaheim, California on Tuesday, May 22, ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 3Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... announced the release of version 5.2 of the FirstSpirit Content Management System with ... initiative. With the new version of FirstSpirit, companies will be well on their ...
(Date:9/1/2015)... ... September 01, 2015 , ... Two of Washington D.C.’s most respected ... food and dining. , Recently named “the next big thing” in the culinary ... for telling the whole story behind food and reclaiming culinary traditions on the brink ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... the 2015-2016 Distinguished Nurse Scholar-in Residence at the Institute of Medicine (IOM) of ... of Biomedical Informatics at Columbia University School of Nursing. A member of the ...
(Date:9/1/2015)... ... September 01, 2015 , ... USA Medical Card, a ... week to coincide with back-to-school and the start of “sick season” for many ... elementary school children are sick an average of 8 to 12 times each ...
(Date:9/1/2015)... Texas (PRWEB) , ... September ... ... LLC, announced today it has established the MAP Recovery Network, the Premier ... addiction treatment providers. This rapidly-growing alliance is dedicated to the provision of ...
Breaking Medicine News(10 mins):Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:MAP Health Management Launches the MAP Recovery Network 2
... 9 The,National Hospice and Palliative Care ... cash grant of $250,000 from a court-approved ... arts, education and,underserved populations., NHPCO will ... and,web-based educational opportunities for hospice professionals, support,research ...
... Heartland is pleased to,announce that their group underwriting ... earned a record dividend of more than $750,000. ... group,s 48 members, which,achieved an outstanding loss ratio ... The Iowa Association of Community Providers (IACP) ...
... more than 600,000 kids taking,part across the country, ... But, no national studies about injury rates in ... to this report from Nationwide Children,s Hospital at:, ... audio, text, graphics and,photos for free and unrestricted ...
... A company founded by an,industry veteran in the ... distribution outlet for the Japanese "Paro" therapy robot through ... announced,today at the RoboBusiness Conference & Expo 2008 in ... Walter Weisel, began its development,through a meeting set up ...
... The Pennsylvania,Academy of Family Physicians Foundation (PAFP/F) is ... student scholarship programs., "The Commonwealth needs more ... care," said PAFP Foundation President Mary Elizabeth,Roth, MD ... the future of family medicine we have to ...
... in Alaska and the Pacific ... Northwest, ... the healthy energy drink mix that has been embraced,by professional athletes, Hollywood ... its product line in,Alaska, Washington and Oregon., "We are very excited ...
Cached Medicine News:Health News:$250,000 Grant Awarded to National Hospice and Palliative Care Organization from Technology Grant Program 2Health News:$250,000 Grant Awarded to National Hospice and Palliative Care Organization from Technology Grant Program 3Health News:$250,000 Grant Awarded to National Hospice and Palliative Care Organization from Technology Grant Program 4Health News:United Heartland Group Program Earns Record Dividend 2Health News:'Paro,' the Baby Seal Service Robot From Japan, Finds a New Home in the United States With Help From JETRO 2Health News:PAFP Golf Tournament to Benefit Student Programs 2Health News:Zipfizz(R) Announces Distribution Deal With the Odom Corporation 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: